Podcast
Hims House
Hims House is the ultimate podcast for Hims & Hers investors. Hosted by Jonathan Stern and Patrick Lester, Hims House breaks down all the key questions shaping $HIMS — from telehealth and pharma to…
Already have it? Open in the app
Latest episodes
- Enhanced Group CEO: Hot peptide summer is coming — but likely not till 20277 Aug 2026
- 🚨 FDA committee votes "YES" on 6 of 7 peptides — here's what happens next, with Dr. Alex Tatem27 Jul 2026
- The FDA peptides vote is days away. This insider expects approval15 Jul 2026
- Ryan MacDonald: Peptides could be a $30B+ market, and Hims is positioned to win meaningful share7 Jul 2026
- 🚨 EXCLUSIVE: Hims board member David Wells on why he bought $1.2M of Hims1 Jul 2026
- Hedge funder Ignacio Canto on retail cults, Hims as Costco + Netflix, and why Hims has 10x upside24 Jun 2026
- Hedge fund manager Imran Khan bought more Hims at its most hated moment -- here's why16 Jun 2026
- Cremieux - Half of America could be on GLP-1s by 2030 (and why peptides are probably overhyped)10 Jun 2026
- Sagar & Sahil Chopra - Founders of Empower Sleep on AI-powered sleep care and the Hims opportunity26 May 2026
- Eli Dorf (Bask Health) - What is Hims’ moat if anyone can launch a telehealth startup overnight?19 May 2026